Podcasts about medical affairs

Send us Fan MailIn this episode of the Life Science Success Podcast my guest is Simran Padam, MD, APMMC, Executive Director of Medical Affairs at Worldwide Clinical Trials. A physician with 17+ years guiding global studies, she shares insights on medical monitoring, complex oncology and hematology programs, and the clinical judgment behind drug development highlighted in her newsletter, The Medical Monitor's Desk.00:00 Show Intro and Guest01:49 Simran Career Journey04:22 Why CRO Variety Matters05:48 What Medical Monitors Do08:04 Protocol vs Reality09:43 Physicians Role Evolving11:14 Better Trial Decisions13:31 Newsletter Behind Scenes16:09 LinkedIn Newsletter Reach17:07 From Science to Execution19:18 Therapeutic Specialization21:20 Collaboration Across Teams23:05 Capabilities for Future25:16 Rapid Fire Inspiration32:44 Where to Connect34:09 Podcast Outro

David Miller, MD, MPH, CEO of Michigan Medicine and EVP for Medical Affairs, University of Michigan joined Rich Helppie from The Common Bridge Podcast May 27 at the 2026 Mackinac Policy Conference to discuss how hospitals are always caring for their communities and always advancing the health of the state. To learn more, visit MIHospitals.org. To subscribe to The Common Bridge Podcast, visit thecommonbridge.com.

Welcome to Episode 4 of the SciTech Critical Evaluation of Literature and AI Series: “Smarter Summaries, Better Decisions: AI Across Medical Affairs"Medical Affairs teams handle a flood of scientific data, so how can AI help turn complexity into clarity? Join experts from the MAPS Scientific & Technical Knowledge Domain to discover how AI tools evaluate evidence for diverse functions, from field teams to HEOR and publications.In this session, you'll learn practical strategies for creating concise, decision-ready summaries and explore why context and clinical relevance must guide every AI-driven workflow. If you want to leverage AI to evaluate evidence, podcast is for you!Learning Objectives:Describe how AI tools adapt evidence evaluation for different Medical Affairs functionsExplore how field medical, medical communications, publications, medical information, and HEOR teams can prompt the same data set differently to generate outputs tailored to their specific needs.Demonstrate strategies to create concise, decision-ready summaries using AILearn practical prompting and structuring techniques that convert complex scientific literature into clear, stakeholder-specific deliverables that support better strategic and scientific decisions.Explain why context and applicability are essential in AI-enabled evidence workflowsUnderstand how role-specific context, intended use, and decision impact must guide both the prompting and interpretation of AI-generated outputs.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

Today, we are talking about a true paradigm shift in prenatal genetics. For decades, we've relied on cell-free DNA for screening, but when it came to definitive confirmation of fetal aneuploidy, we've had to counsel our patients through the anxiety and physical risks of invasive procedures like amniocentesis and CVS. But what if the line between screening and confirmation just blurred? In this episode, we are diving into an avant-garde, first-of-its-kind maternal blood test that is now actively in clinical use and may prove to rival traditional invasive testing for fetal aneuploidy confirmation: the Unity CONFIRM test. To break down the cutting-edge science, the clinical validity, and exactly what this means for your daily practice, I am thrilled to welcome Jen Hoskovec, the Vice President of Medical Affairs for BillionToOne. You might have recently seen her insights featured alongside Dr. Haywood Brown in Contemporary OB/GYN, and today, she's here with us. We're going to discuss the availability of this test, the technology that makes it possible, and what the next concrete steps are for integrating this into modern obstetrical care. Grab your coffee. Let's get into the science.1. https://www.contemporaryobgyn.net/view/haywood-brown-md-jennifer-hoskovec-explain-new-non-invasive-confirmatory-test2. Screening for Fetal Chromosomal Abnormalities PA; January 2026

At the SOAP meeting in Montreal, Desiree Chappell and Monty Mythen interview Dr. Marie Louise Meng, Assistant Professor of Anesthesiology at Duke University Department of Anesthesiology and her former cardio-obstetric fellow Liliane Ernst, assistant professor in the Obstetric and Gynecologic Anesthesia section Wake Forest University. The conversation focuses on cardio-obstetric anesthesia, hemodynamics, monitoring, and patient-centered care. Meng describes building multidisciplinary "pregnancy heart teams" to plan management for complex cardiac disease in pregnancy and reduce birth trauma. Ernst discusses research using the Premier database on preexisting atrial fibrillation in pregnancy (about 25 per 100,000 deliveries) and associated management and outcomes. They review cases including mechanical circulatory support with an Impella to prolong pregnancy and highlight knowledge gaps about placental perfusion and pulsatility, including Fontan physiology. Meng outlines individualized hemodynamic monitoring for labor and C-sections, emphasizes recognizing hypertensive instability, and details preeclampsia with severe features, its end-organ criteria, incidence, disparities, postpartum follow-up challenges, and potential use of remote monitoring and noninvasive cardiac output/SVR monitoring to guide therapy. Monty Mythen, founding editor-in-chief of TopMedTalk, is now Senior Vice President, Scientific Liaison, BD Advanced Patient Monitoring. He is also Emeritus Professor of Anaesthesia and Critical Care, University College London, UK. Desirée Chappell, former co-editor-in-chief of TopMedTalk, is now Director of Medical Affairs and Medical Science Liaison, BD Advanced Patient Monitoring. She is also a CRNA at NorthStar Anesthesia, USA. -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - EBPOM World Congress 2026

Host Polly Swingle is joined by Lauren Sauders, MOTR/L, CBIS, CSRS, and Vice President of Medical Affairs at Neurolutions, to talk about the IpsiHand device for stroke recovery.As an occupational therapist by training, Lauren has spent her entire career in adult neurorehabilitation. She began as a clinician at The Rehabilitation Institute of St. Louis, an affiliate of Washington University in St. Louis, where she worked alongside the research team that conceived IpsiHand in its earliest days. She helped author the initial study protocol and has grown with the company ever since - shepherding the technology through clinical trials, peer‑reviewed publications, and the regulatory pathway that earned IpsiHand both FDA Breakthrough Device designation and De Novo clearance. After clearance, she helped lead the organization through commercialization and into broader clinical adoption. Lauren has authored numerous publications and delivered presentations at national and international forums, but her most enduring focus is advocacy: ensuring that stroke survivors have evidence‑based access to therapies that meaningfully improve their quality of life. That mission is personal. Beyond the patients she has cared for, Lauren brought her grandmother into her own home during the COVID‑19 pandemic and cared for her after she sustained a severe stroke — an experience that deepened her understanding of the toll stroke takes on families as well as individuals. She is also a mother of three, including a child with a rare neurogenetic condition, and is a passionate advocate within the pediatric neuro-community as well. Her and her husband also share their home with three crazy dogs. When she isn't working or advocating, she can most often be found visiting family in Bermuda.Click the link below to visit the IpsiHand by Kandu website-https://www.neurolutions.com/Learn more about The Recovery Project!View our website at www.therecoveryproject.netCall us 855-877-1944 to become a patientFollow us on InstagramLike us on FacebookThanks for listening! 

Welcome to Episode 3 of the SciTech Critical Evaluation of Literature and AI Series: “Humans + AI: Making Sense of Scientific Papers at Scale"AI can read hundreds of scientific papers in minutes, but can it truly understand them? Join experts from the MAPS Scientific & Technical Knowledge Domain to explore how artificial intelligence is reshaping literature review in Medical Affairs.In this session, you'll learn what AI can and cannot do with scientific content, uncover practical applications of leading tools like CoPilot and Notebook LM. We'll also tackle common risks such as hallucinations and lack of context, and share strategies to validate AI outputs while keeping clinical judgment front and center. If you want to harness AI without losing the human touch, this webinar is for you!Learning Objectives:Understand what AI can—and cannot—do with scientific literatureExplain how AI processes papers using NLP and LLMs, and why clinical judgment remains essential.Explore practical applications of leading AI toolsReview the capabilities, pros, and cons of tools like CoPilot and Notebook LM for Medical Affairs workflows.Recognize limitations and risks in AI-driven literature reviewIdentify common issues such as hallucinations, lack of context, and strategies to validate AI outputs.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

In this episode, Jon Alford, CFO, UW Medicine and Vice President for Medical Affairs at the University of Washington, joins the podcast to discuss the evolving financial challenges facing academic medical centers, from labor costs to reimbursement pressures. He also shares how automation, operational efficiency, and frontline engagement are shaping his leadership approach in his new role.Learn more about relentlessly raising RCM yield here: https://med-metrix.com/?utm_source=beckers&utm_medium=podcast&utm_campaign=brand

In this episode, Claudia Lucchinetti, MD, VP of Medical Affairs and Dean of the UT Austin Dell Medical School, discusses building an AI-native academic medical center, expanding access to advanced care in Central Texas, and integrating research, education, and clinical care into one connected ecosystem.

Welcome to Episode 2 of the SciTech Critical Evaluation of Literature and AI Series: “Literature Never Sleeps: Staying Ahead Without Burning Out"Literature never sleeps and neither do the challenges of keeping Medical Affairs teams up to date.Join experts from the MAPS Scientific & Technical Knowledge Domain to discover practical strategies for managing the deluge of data. We'll explore how AI can accelerate evidence synthesis while highlighting its limitations and the critical role of human judgment. If you're looking for smarter ways to stay current, this podcast is for you!Learning Objectives:Identify key challenges in keeping Medical Affairs teams currentUnderstand the impact of preprints, grey literature, bibliometrics, and predatory journals on evidence appraisal.Evaluate the role and limitations of AI in literature reviewRecognize how AI can accelerate evidence evaluation while appreciating the need for human judgment and safeguards against errors.Apply best practices for confidentiality and critical assessment of AI outputsLearn practical steps to ensure secure data handling and train teams to validate AI-generated insights effectively.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

In this episode, Ilan Shapiro, MD, MBA, FAAP, FACHE, Chief Health Correspondent and Medical Affairs Officer and Senior Vice President at AltaMed Health Services, joins the podcast to discuss breaking language barriers in healthcare and closing gaps between patients and providers. He shares how improving communication and cultural understanding can lead to better access, stronger relationships, and improved health outcomes.

In this episode, Ilan Shapiro, MD, MBA, FAAP, FACHE, Chief Health Correspondent and Medical Affairs Officer and Senior Vice President at AltaMed Health Services, joins the podcast to discuss breaking language barriers in healthcare and closing gaps between patients and providers. He shares how improving communication and cultural understanding can lead to better access, stronger relationships, and improved health outcomes.

In this episode, Kelli Tice, MD, Vice President of Medical Affairs and Chief Health Improvement Officer at GuideWell and Florida Blue, joins the podcast to discuss navigating healthcare with limited resources while continuing to improve outcomes. She shares insights on advancing maternal health, the importance of thoughtful decision-making, and how leadership choices can create meaningful impact across populations and communities.

In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick speaks with Nick Sarlis, MD, PhD, FACP, Chief Medical Officer at Clara Biotech, about why successful biotech launches begin years before approval. Drawing on experience across six product launches and nine indications, Nick shares a practical CMO perspective on building medical affairs capabilities early, aligning scientific strategy across functions, and preparing organizations for launch success in today's biotech environment. Nick explains why "T-minus 30 months" is becoming the new standard for launch preparation and discusses the foundational role of medical affairs in shaping scientific narrative, publication strategy, KOL engagement, field medical deployment, and long-term evidence generation planning. The conversation also explores: • Early hiring strategy for medical affairs teams • Building experienced MSL and field medical capabilities • Aligning medical, commercial, and corporate communications • Publication planning and scientific congress engagement • Academic center and patient advocacy partnerships • Managing actionable MSL insights • Evidence generation planning beyond approval • Launch readiness in resource-constrained biotech organizations A practical, resource and strategy-focused discussion for biotech executives, CMOs, medical affairs leaders, MSLs, and clinical-stage companies considering commercialization.

In this episode, Kelli Tice, MD, Vice President of Medical Affairs and Chief Health Improvement Officer at GuideWell and Florida Blue, joins the podcast to discuss navigating healthcare with limited resources while continuing to improve outcomes. She shares insights on advancing maternal health, the importance of thoughtful decision-making, and how leadership choices can create meaningful impact across populations and communities.

In the final part of this 3-part series, experts from the MAPS Leadership and Management Domain wrap up their discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?Through this episode, Medical Affairs professionals may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.

Menopause gets reduced to hot flashes, whispered about like it's a personal flaw, then brushed off in the exam room when symptoms don't fit a neat box. That silence has a cost. Cardiologist Dr. Jayne Morgan joins us to explain why menopause is a cardiovascular turning point, and why so many women feel dismissed with “normal labs” while their bodies are waving real warning flags.In this episode, we talk about an uncomfortable truth: many clinicians receive little to no menopause training, and it still isn't meaningfully reflected in many clinical guidelines. Dr. Morgan breaks down how that gap leads to fragmented care, in which palpitations, dizziness, bloating, joint pain, or even itchy ears are treated as separate mysteries rather than a connected syndrome. We also unpack how language like “atypical” chest pain can quietly lower urgency for women, even though heart disease remains the number one killer of women, and risk can rise sharply during perimenopause as estrogen declines.Connect with Dr. Morgan at·       Facebook – https://www.facebook.com/FortyMIlionBeats/·       Instagram – https://www.instagram.com/drjaynemorgan/·       TikTok – https://www.tiktok.com/@DrJayneMorgan

In Part 2 of this 3-part series, experts from the MAPS Leadership and Management Domain continue this discussion on understanding change. How does it impact our teams, and how can our leaders guide their teams through change?Through this episode, Medical Affairs professionals may gain a better understanding of why change feels so hard right now and learn about what we can do to support each other and really thrive during these times of uncertainty.

In this powerful live episode recorded at our live “Reality of Infertility” event in Los Angeles, Love is Blind Season 7 cast member, Monica Jade Davis shares the deeply personal story behind her fertility journey.Known to many from reality TV, Monica opens up about her relationship with partner Zac, their diagnosis of unexplained infertility, and the emotional reality of undergoing four back-to-back IVF cycles - including the highs of retrieving 90 eggs and the heartbreak of struggling to reach viable embryos.She talks candidly about:What surprised her most about IVFThe mental and emotional toll of repeated failed cyclesHow sharing her journey online transformed her connection to communityWhy she wishes she had frozen her eggs earlierAnd how she's learning to reclaim her identity outside of infertilityWhat carries Monica forward is a hard-earned belief that this chapter isn't the end of her story. If anything, this journey has deepened her dream of becoming a mother and strengthened her certainty that she will be one someday. Yet another chapter in her love story.This inspiring episode also features an informative mid-roll segment with episode sponsor, Tru Niagen. Mona Rosene, MS, RD, Global Director, Scientific & Medical Affairs, Niagen Bioscience​ educates us on the importance of NAD for issues like inflammation and to support mitochondrial and cellular health. Use our code EGGS20 at to get 20% off at TruNiagen.com. Hosted on Acast. See acast.com/privacy for more information.

Host: Matt Birnholz, MD Guest: Renu Juneja, PhD What do pharmaceutical leaders actually need from their agency partners? Find out as Dr. Matt Birnholz sits down with Dr. Renu Juneja to explore how insight-led collaboration can unlock stronger relationships, faster timelines, and more impactful medical education. In this conversation at the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, they share perspectives on how challenging assumptions, leveraging artificial intelligence, and developing scalable strategies can help deliver meaningful value. Dr. Juneja is the President of ADPAL LLC, a boutique company advising consulting firms and agency partners.

Host: Matt Birnholz, MD Guest: Tony Page Early, integrated insights can dramatically improve pharmaceutical launch outcomes and reduce the risk of missed expectations. Discover best practices for aligning market needs with clinical strategy and leveraging AI for smarter insight planning with Dr. Matt Birnholz and Mr. Tony Page, who shared their perspectives at the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting. Mr. Page is the Senior Vice President of Insight at Within3, a platform dedicated to launch insights.

Host: Matt Birnholz, MD Guest: Karen Roy, MSc For medical affairs teams, demonstrating the value and impact of educational initiatives in a meaningful and measurable way is essential. At the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting, Dr. Matt Birnholz spoke with Ms. Karen Roy, CEO and Co-Founder of Infograph-ed, about how CME-informed strategies can elevate planning, content design, and outcomes measurement. Learn more about new approaches that can help create more targeted, insight-driven education.

Host: Matt Birnholz, MD Guest: Michael DeLuca, PharmD, MBA, MSRA From launch excellence to global operational support, medical affairs teams are evolving to enhance scientific exchange and drive meaningful outcomes for patients. Learn more with Dr. Matt Birnholz and Dr. Michael DeLuca, Executive Vice President of Global Medical Affairs and Medical Information at EVERSANA, who explored key trends shaping the field at the 2026 Medical Affairs Professional Society (MAPS) Annual Meeting. Hear about how artificial intelligence and other innovations are transforming data generation, insight development, and engagement strategies.

At the 19th World Congress of the Societies of Anaesthesiologists (WCSA 2026) in Marrakesh, TopMedTalk welcomes Desiree Chappell back alongside Kate Leslie to interview Professor Palesa Motshabi-Chakane, Associate Professor and Head of Anaesthesiology at the University of the Witwatersrand and her colleague, Dr Mullai Slave a PhD candidate at University of the Witwatersrand. They discuss a study of 629 women undergoing cesarean section with spinal anesthesia at Chris Hani Baragwanath Hospital, where 23–33% are HIV positive. Using standard monitoring plus BD APM noninvasive continuous hemodynamic monitoring, they compared HIV-positive and HIV-negative patients and found higher hypotension incidence in HIV-positive women (68% vs 64%), with lower heart rate and lower cardiac index over 60 minutes. Additional testing included echocardiography with speckle tracking, pro-BNP, and autonomic assessments, with HIV-positive patients showing stiffer ventricles; Apgar scores did not differ. They discuss replication, multicenter research, and potential machine-learning tools to predict hypotension risk, and describe BD Advanced Patient Monitoring grant support enabling equipment, sensors, staffing, and training (~200 staff) to complete data collection in about six months. Edwards Lifesciences is now known as Becton Dickinson Advanced Patient Monitoring (BD APM). Desiree Chappell, former Co Editor in Chief of TopMedTalk, is now Director, Medical Science Liaison, Medical Affairs, BD Advanced Patient Monitoring. The views expressed on this program are her own and not those of her employers. We mention Adrian Gelb, if you'd like to hear his recent conversation with us go here: https://topmedtalk.libsyn.com/professor-adrian-gelb-on-patient-safety-and-essential-medicines-in-anaesthesia -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood. Register here - https://ebpom.org/product/ebpom-world-congress-2026/  

What if the decisions that determine your drug's commercial success are already being made and medical affairs isn't in the room? In this episode of Medical Affairs Unscripted, Peg Crowley speaks with Nick Sen, SVP and Practice Lead at Lumanity Medical Affairs Consulting, about the evolving role of medical affairs as a strategic driver in biotech and pharmaceutical development. Drawing on experience across academia, commercial strategy, and market access, Nick explains why early medical engagement is no longer optional even for resource-constrained biotech companies. Instead, it is a critical lever for improving clinical, regulatory, and commercial outcomes. They explore three core pillars of medical affairs impact: De-risking clinical development by shaping the Target Product Profile (TPP) with real-world clinical and stakeholder insight Accelerating regulatory approval through early investigator engagement, site selection, and improved trial enrollment Enabling market access and adoption by building an evidence strategy aligned with payer, provider, and patient needs As scientific innovation accelerates across cell therapies, gene therapies, and complex biologics biotech companies must move beyond a narrow focus on regulatory approval and design development programs for real-world adoption and value demonstration. This episode is essential for biotech executives, medical affairs leaders, and cross-functional teams looking to integrate medical strategy earlier in clinical development and strengthen the probability of successful commercialization.

Building and demonstrating medical impact is becoming a central priority for organizations seeking to deliver meaningful outcomes for patients, healthcare systems, and society. But what does it take to design, implement, and sustain an effective impact framework within a medical affairs setting? In this podcast, we bring together medical leaders who have successfully navigated this journey in their own organizations.Through an engaging discussion, they share the motivations that drove their initiatives - whether responding to unmet needs, seizing strategic opportunities, or adapting to evolving organizational contexts. Listeners will hear practical insights into how frameworks were designed, the principles that guided them, and how approaches were tailored to align with specific structures, cultures, and therapeutic areas.The conversation also explores real-world outcomes: how impact is measured and recognized, what changes have emerged since implementation, and the role of data and technology in accelerating progress. Leaders candidly reflect on unexpected challenges and benefits, while offering practical advice for peers who are starting or refining their own frameworks.Looking ahead, our speakers share their perspectives on the future evolution of impact capabilities-and the enablers that will drive success in the years to come.

Dr. Mandelbaum  is among the world's foremost experts in the diagnosis and treatment of orthopedic conditions, especially those related to the knee. He practices at and serves as Co-Chair of Medical Affairs for Cedars-Sinai Orthopaedics in Los Angeles, CA. Dr. Mandelbaum is the Chief Medical Officer for the US Soccer Federation and the team physician for the US Men's National Team.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of Core Conversations with Natalie Baggio, we explore how clinical leadership and innovation are shaping the future of health care in Southwest Michigan. Natalie is joined by Dr. John Froggatt, Vice President of Medical Affairs and Infectious Disease Physician, who has practiced locally for 27 years. Dr. Froggatt shares exciting news about a new stroke treatment service launching soon - A procedure that physically removes blood clots in the brain, restoring blood flow quickly and improving outcomes. Offering this advanced care locally means faster treatment, saved lives, and fewer patients needing to leave the community during critical moments. The conversation also highlights powerful improvements in care for patients living with sickle cell disease. Through system-wide collaboration, new standards of care, and stronger outpatient connections, patients are experiencing fewer hospital visits, shorter stays, and better quality of life. Dr. Froggatt reflects on what makes his work most meaningful today, building high-performing physician teams, strengthening quality, and embracing new technologies like artificial intelligence to continuously improve patient care. Hear how thoughtful leadership, collaboration, and innovation are helping keep high-quality care close to home in Southwest Michigan.See omnystudio.com/listener for privacy information.

In this episode of Core Conversations with Natalie Baggio, we explore how clinical leadership and innovation are shaping the future of health care in Southwest Michigan. Natalie is joined by Dr. John Froggatt, Vice President of Medical Affairs and Infectious Disease Physician, who has practiced locally for 27 years. Dr. Froggatt shares exciting news about a new stroke treatment service launching soon - A procedure that physically removes blood clots in the brain, restoring blood flow quickly and improving outcomes. Offering this advanced care locally means faster treatment, saved lives, and fewer patients needing to leave the community during critical moments. The conversation also highlights powerful improvements in care for patients living with sickle cell disease. Through system-wide collaboration, new standards of care, and stronger outpatient connections, patients are experiencing fewer hospital visits, shorter stays, and better quality of life. Dr. Froggatt reflects on what makes his work most meaningful today, building high-performing physician teams, strengthening quality, and embracing new technologies like artificial intelligence to continuously improve patient care. Hear how thoughtful leadership, collaboration, and innovation are helping keep high-quality care close to home in Southwest Michigan.See omnystudio.com/listener for privacy information.

How has cochlear implant care evolved—and are clinical practices keeping pace with today's technology?Brian Taylor speaks with Dr. Terry Zwolan, Senior Director of Medical Affairs at Cochlear Americas, about the evolution of cochlear implants and the newly developed Cochlear™ Care Consensus. Drawing on more than three decades of experience, Dr. Zwolan reflects on how cochlear implant technology—and the patients who use it—have changed, and why clinical care models must evolve alongside these advancements.The conversation explores how early cochlear implant care was shaped by clinical trial protocols, often requiring frequent and lengthy appointments, and contrasts that with today's more efficient technology and patient expectations. Dr. Zwolan also discusses how modern tools, remote care capabilities, and changing clinical workflows are influencing how clinicians deliver care.A central focus is the Cochlear Care Consensus—a set of 57 expert-driven recommendations designed to provide more detailed, practical guidance for clinicians. The consensus blends evidence-based research with real-world clinical expertise, offering insight into areas such as programming, patient management, evaluation, and the use of emerging tools like Remote Check.Learn more about the Cochlear Care Consensus here:https://pronews.cochlear.com/cochlear-care-consensus-recommendations/Cochlear Care Consensus: Expert Guided Care Recommendations (note: to access recording, you will need to create an account)Be sure to subscribe to our channel for the latest episodes each week and follow This Week in Hearing on LinkedIn, Instagram and X.- https://x.com/WeekinHearing- https://www.instagram.com/thisweekinhearing/- https://www.linkedin.com/company/this-week-in-hearingVisit us at: https://hearinghealthmatters.org/thisweek/

When "Denied" Goes Viral: AI Claim Denials, TrumpRx, and America's Healthcare Trust Crisis The Not Old Better Show, Art of Living Interview Series Thank you, I'm Paul Vogelzang. Today's episode is brought to you by Caraway. Good Looking. Clean Cooking. Have you ever stood at the pharmacy counter, card in hand, and heard one word: denied? For our listeners over 50, that moment isn't about inconvenience. It's blood pressure meds. It's insulin. It's the medication that keeps you steady, independent, and in your own life. And then comes the "solution": "Try a coupon." "Pay cash." "Use a marketplace." Behind that advice is a system that can feel like a black box—prior authorization, shifting formularies, and now, more and more, algorithms. AI can speed up decisions, but it can also shut a door without giving you a clear, human explanation. Now add the third ingredient: social media. A nonstop feed that can take real pain and turn it into a blame spiral—until people stop asking, "How do we fix this?" and start asking, "Who do we punish?" We've seen how fast outrage can spread, and how dangerous it can become when it's celebrated instead of cooled down. Today on The Not Old Better Show, we're connecting those dots—insurance hurdles, AI-driven denials, and the polarization that's eroding trust. Our guest is Dr. William Soliman, CEO of the Accreditation Council for Medical Affairs and a leading expert on pharma and health insurance. He'll explain TrumpRx—what it is, what it isn't, and why a discount price that doesn't count toward your deductible can backfire for seniors on multiple medications. We'll talk reform. We'll talk responsible tech. And we'll talk empathy—because healthcare can't run on anger. And it's never too late to insist on dignity at the doctor's office. Remember, support our sponsors: today's episode is brought to you by Caraway. Good Looking. Clean Cooking.

Bonus episode! I had the opportunity to talk to the folks at Dexcom about their presentations at ATTD and I wanted to bring you the interview sooner rather than later. ATTD is the Advanced Technology and Treatments for Diabetes conference, this year it took place in Barcelona. If you're new around here, there are a few big diabetes conferences where studies are presented and news is made. ATTD in spring, ADA and ADCES in summer and a few more scattered here and there. We'll be sharing more from ATTD in upcoming interviews with other tech companies. But today I'm talking to Jessica Castle, VP of Medical Affairs at Dexcom – she's also an adult endocrinologist with a lot of clinical trial experience. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

Have you heard about Embody yet? It's a brand new platform that includes community support to assist you with maintaining a healthy lifestyle and overall well-being. Mark finds out the skinny with Dr. Brunilda Nazario,Chief Physician Editor, Medical Affairs at Web MD.

Health misinformation is a critical threat to global public health. It erodes confidence in vaccines and medicines, fuels pandemic denialism, promotes unproven treatments, and undermines public health efforts. Medical Affairs sits at the centre of this challenge. We have a clear ethical responsibility to ensure patients make informed, evidence-based decisions about their care, and to equip healthcare professionals with the information and tools needed to address misinformation in the clinical setting. However, this approach carries inherent time and resource limitations.In this episode, we explore the role of Digital Opinion Leaders (DOLs) as a core pillar of modern healthcare communications. DOLs have the power to shape conversations, steer search behaviours, and can either amplify misinformation or help correct it. We examine the different DOL profiles and personas, discuss best practices for building effective long-term partnerships that leverage their individuality, preferences, and regional specificities, and consider how DOL engagement should be embedded into medical and cross-functional planning.We will draw on early insights from an ongoing pilot in Sub-Saharan Africa, analysing how patients and healthcare workers use social platforms and messaging apps – enabling us to identify trusted DOLs we can partner with to design effective health education and advocacy programmes.  

In this episode, Ericka Powell, MD, Vice President of Medical Affairs at WellSpan Ephrata Community Hospital within WellSpan Health, discusses reducing length of stay variation, strengthening physician engagement, and using data driven care pathways to improve quality, workforce stability, and value based performance.

In this episode, Ericka Powell, MD, Vice President of Medical Affairs at WellSpan Ephrata Community Hospital within WellSpan Health, discusses reducing length of stay variation, strengthening physician engagement, and using data driven care pathways to improve quality, workforce stability, and value based performance.

On today's MAPS "Elevate" episode, we'll deep dive into how Medical Affairs professionals can strengthen their business knowledge, expand their influence across organizations, and position themselves for executive leadership. Through personal stories and practical advice, our speakers reveal how. through working with and absorbing business acumen, they are helping people become more effective and more strategic leaders, and rising within their organizations.Learning Objectives:By the end of this podcast, listeners will learn:Why business acumen is importantWhat the balance is between business and medical needsWhat motivates companies to develop and commercialize a new medicineHow Medical Affairs adds valueWhat qualities make a great partnerSpeakers:Moderator: Michael Kahn, Executive Director, Medical Excellence, Amicus TherapeuticsLINKEDIN: https://www.linkedin.com/in/kahnmichael/Speaker 1: René Russo, PharmD, President & CEO, Xilio TherapeuticsLINKEDIN: https://www.linkedin.com/in/rene-russo-7488966/Speaker 2: Ruth du Moulin, PhD, SVP Medical Affairs, Xilio TherapeuticsLINKEDIN: https://www.linkedin.com/in/ruth-du-moulin-phd-472b843/

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and education space. The Perry Academy was created for

In this episode, Peg Crowley-Nowick speaks with Joseph Elassal, MD, MBA, Chief Medical Officer of Ankyra Therapeutics, about the strategic, operational, and financial realities of leading clinical development from pre-IND through proof of concept and toward commercialization.   Drawing on experience across large pharma, biotech partnerships, and early-phase oncology, Joe shares a practical roadmap for new and aspiring CMOs. They discuss how to prioritize essential capabilities, including clinical operations, regulatory strategy, biostatistics, and pharmacovigilance, while determining the right time to introduce Medical Affairs. The conversation outlines how to scale teams at critical inflection points such as IND clearance, Phase 2 proof of concept, and advancement into Phase 3.   The episode also examines investor and board expectations, CRO selection, capital efficiency, cash runway management, and the performance metrics CMOs are ultimately judged on—from disciplined milestone execution to generating meaningful clinical data. This episode offers actionable insight for biotech founders, clinical development leaders, medical affairs professionals, and emerging CMOs navigating the path from early development to launch.

I am excited to welcome Dr. Jayne Morgan as my guest today. She is a cardiologist and the Vice President of Medical Affairs at Hello Heart, specializing in women's health and cardiovascular research. In our conversation, we look at the gaps in clinicians' training around perimenopause and menopause, also discussing gender neutral training, and how men and women are treated differently in the medical system. Dr. Morgan shares her preferred areas of focus when educating middle-aged women about hormone replacement therapy and clusters of diagnoses, which include diabetes, dyslipidemia, high blood pressure, and weight-loss resistance. We examine how myocardial infarctions (heart attacks) tend to manifest differently in women, often with microvascular disease, atypical chest pain, and less obvious symptom patterns. We also explore screening recommendations, such as EKGs, Lp(a) assessments, and mammography for microcalcifications, which might indicate an elevated risk for cardiovascular disease. This fun and lively conversation with Dr. Morgan offers valuable, practical insights into women's heart health. I look forward to recording future podcast episodes with her. IN THIS EPISODE, YOU WILL LEARN: One-size-fits-all treatment of women during medical training in the '90s and early 2000s Speaking up in the exam room when something doesn't feel right When hormone therapy was labeled dangerous, and the fallout that followed Medicine's uncomfortable truth: clinicians must keep learning or fall behind Gender-neutral cardiology and the women it left behind The midlife risk-factor pileup no one prepared women for  Why not taking blood pressure or cholesterol medications is risky rather than healthy Heart attacks often mistaken for anxiety, especially in women Slow change, real progress in women's cardiology care Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Jayne Morgan On Instagram, TikTok, Threads, YouTube, and LinkedIn

In this episode of Health Gig, Doro and Tricia welcome Dr. Eva Selhub, Chief of Medical Affairs at ForHumanity. Dr. Selhub talks about her journey within the medical field, which was shaped by personal experiences that led her to rethink traditional healthcare. Through her work at ForHumanity, she is an educator on personalized healthcare delivery and the significance of understanding bio-individuality. Dr. Selhub leaves listeners with the understating that while health comes from practice and medicines, true wellness stems from compassion and self-love.

How Medical Affairs leaders can move their organizations from a supporting role to a strategic driver—through accountability, insight translation, and the smart use of AI. In this episode of Medical Affairs Unscripted, Peg Crowley-Nowick speaks with Greg Carpenter, Global Medical Strategy Leader in General Medicine at Sanofi, for a candid conversation on how Medical Affairs must evolve to remain relevant—and indispensable—in a rapidly changing industry. The discussion focuses on how Medical Affairs leaders can increase their strategic impact across pharma and biopharma organizations. Drawing on experience across commercial, quality, and Medical Affairs functions, Carpenter outlines why broader career paths, business acumen, and accountability are essential to creating Medical Affairs value. The conversation examines how Medical Affairs can move beyond data delivery to translate medical insights into strategy, strengthen cross-functional collaboration, and better support physicians and patients. The episode concludes with a practical discussion on AI in Medical Affairs, including how AI is being used today to improve insights, content development, and efficiency—while reinforcing the importance of human judgment and leadership.

Did you know that nearly 50% of women experience hair changes during menopause? In this expert-led conversation, we uncover the truth behind menopausal hair thinning, shedding, and texture changes with Dr. Isabelle Raymond, SVP of Clinical and Medical Affairs at Nutrafol. Dr. Raymond is dedicated to advancing women's health, with a particular focus on the biological and lifestyle factors that impact hair health during midlife. We explore the six root causes of hair thinning, the critical role of nutrition and hormones in hair growth, and why clinically backed research is essential for proven hair wellness solutions. Show Notes/Links: www.hotflashescooltopics.com Nutrafol: Link WE GREATLY APPRECIATE 5 STARS AND REVIEWS! Find Us Here! Website I [http://hotflashescooltopics.com/] Mail I [hotflashescooltopics@gmail.com] Instagram I [https://www.instagram.com/hotflashesandcooltopics/] Facebook : [www.facebook.com/hotflashescooltopics] YouTube I [https://www.youtube.com/@HotFlashesCoolTopics] Pinterest I [https://www.pinterest.com/hcooltopics/]

In this episode, Dr. Sriram Vissa, Chief Medical Officer and Vice President of Medical Affairs at SSM Health DePaul Hospital, shares how multidisciplinary teamwork and data driven care progression improved safety, efficiency, and length of stay, while outlining priorities for behavioral health access, workforce stability, and growth in 2026.

Your heart attack won't look like the movies—and that ignorance is killing women. Dr. Jayne Morgan, renowned cardiologist and VP of Medical Affairs at Hello Heart, shares a shocking truth: women wait 37 minutes longer for care than men, and each minute increases your risk of dying. Discover why fatigue and jaw pain might be your body's SOS, how menopause impacts your natural heart protection, and the one phrase that gets immediate ER attention. Heart disease is women's #1 killer, yet we're dismissed as "atypical." Arm yourself with knowledge that saves lives, beauties—starting now. FOLLOW A CERTAIN AGE ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ GET INBOX INSPO: Sign up for our newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠AGE BOLDLY⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We share new episodes, giveaways, links we love, and midlife resources Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Ryan Gober, Medical Science Liaison at Electromedical Products International (EPI). Dr. Gober shares his insights on the science behind Alpha-Stim, its clinical applications for anxiety, insomnia, and pain, and the role of non-invasive brain stimulation in mental health treatment.Electromedical Products International (EPI) is a medical device company specializing in developing neuromodulation technologies including its flagship product, Alpha-Stim.   Alpha-Stim is a FDA cleared medical device which utilizes a form of non-invasive electrical stimulation  to treat symptoms of anxiety, insomnia, and pain.  Ryan Gober is a Medical Science Liaison with EPI's Medical Affairs team responsible for sharing scientific and clinical information related to the Alpha-Stim device.  Prior to joining EPI, Ryan completed an NIH research fellowship followed by a PhD in translational neuroscience where he performed research on behavioral health conditions and developed an interest in non-pharmacological options for treating mental health conditions, leading him to join Alpha-Stim.  SHOWNOTES: 

In this episode, Denise J. Jamieson, MD, MPH, Vice President for Medical Affairs and Dean of the Carver College of Medicine at University of Iowa Health Care, shares her journey from the CDC to academic leadership, the mission of serving Iowa, and her priorities around physician workforce development, mentorship, and sustaining impact in healthcare.